by Lyla El-Fayomi | May 23, 2024
“Regenerative medicine news under the microscope” is a monthly feature highlighting a selection of impactful research findings and headlines across the many subfields of regenerative medicine. I’ve gone slightly longer form with this month’s edition, as I found that...
by Medicine by Design | May 13, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of profiles that feature “people” of Medicine by Design. Some minor edits...
by Medicine by Design | May 6, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of profiles that feature “people” of Medicine by Design. Some minor edits...
by Medicine by Design | Apr 15, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of profiles that feature “people of Medicine by Design.” Some minor edits...
by Krystal Jacques | Apr 11, 2024
In current organoid technologies, human pluripotent stem cells are guided to differentiate into 3D structures that resemble the corresponding human in-vivo organ, which allows researchers the opportunity to study the organ’s specific cells and function. However,...
by Lyla El-Fayomi | Apr 4, 2024
Regenerative Medicine News Under the Microscope is back! Thank you all for your patience as I wrapped up my PhD; the hiatus is officially over. We’re celebrating the return of this feature with a double header covering regenerative medicine research highlights from...
Comments